Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method

• Hlavní autoři: Dhawal Raghuvanshi (Autor), Gregory Nkepang (Autor), Alamdar Hussain (Autor), Hooman Yari (Autor), Vibhudutta Awasthi (Autor)
• Médium: Kniha
• Vydáno: Elsevier, 2017-02-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

CLEFMA, 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid, is a new chemical entity with anti-cancer and anti-inflammatory activities. Here, we report its stability in solution against stress conditions of exposure to acid/base, light, oxidant, high temperature, and plasma...